-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics Files Prospectus Related To Resale Of Up To 6M ADSs Representing 480B Ordinary Shares By The Selling Shareholders

Benzinga·07/02/2026 21:30:29
Listen to the news

-SEC Filing